20-23036120-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001052.4(SSTR4):c.637G>T(p.Val213Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000081 in 1,604,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001052.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SSTR4 | NM_001052.4 | c.637G>T | p.Val213Phe | missense_variant | 1/1 | ENST00000255008.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SSTR4 | ENST00000255008.5 | c.637G>T | p.Val213Phe | missense_variant | 1/1 | NM_001052.4 | P1 | ||
ENST00000440921.6 | n.827-2103G>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000565 AC: 86AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000873 AC: 21AN: 240574Hom.: 0 AF XY: 0.0000991 AC XY: 13AN XY: 131172
GnomAD4 exome AF: 0.0000303 AC: 44AN: 1452086Hom.: 0 Cov.: 30 AF XY: 0.0000208 AC XY: 15AN XY: 722718
GnomAD4 genome AF: 0.000565 AC: 86AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.000551 AC XY: 41AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2023 | The c.637G>T (p.V213F) alteration is located in exon 1 (coding exon 1) of the SSTR4 gene. This alteration results from a G to T substitution at nucleotide position 637, causing the valine (V) at amino acid position 213 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at